Sector ratings Beam Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/02/2026 GMT			5-day change	1st Jan Change
26.95 ^USD	-1.21%		-3.47%	-2.78%

02-05	Beam Therapeutics Inc. Announces Resignation of Carole Ho from the Board of Directors, Effective February 27, 2026	CI
01-14	Beam Therapeutics Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 05:15 PM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
BEAM THERAPEUTICS INC.	2.69B	-	BB	-		-
LONZA GROUP AG	47.17B		AAA
SEAGEN INC.	43.15B	-	-	-	-	-	-	-
BEONE MEDICINES AG	38.6B		-
CELLTRION, INC.	34.53B		A
IQVIA HOLDINGS INC.	32.68B		AAA
IMMUNOMEDICS, INC.	20.32B	-	-	-	-	-	-	-
REVOLUTION MEDICINES, INC.	18.7B	-	B	-		-
PPD, INC.	16.61B	-	-	-	-	-	-	-
MEDPACE HOLDINGS, INC.	14.94B		BBB
EUROFINS SCIENTIFIC SE	14.13B		AA
IONIS PHARMACEUTICALS, INC.	13.73B	-	A	-		-
ASCENDIS PHARMA A/S	13.63B	-	-	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	13.7B	-	-	-	-	-	-	-
ICON PUBLIC LIMITED COMPANY	11.8B		AA
PRA HEALTH SCIENCES, INC.	10.96B	-	-	-	-	-	-	-
QIAGEN N.V.	10.46B		AAA
BIO-TECHNE CORPORATION	10.24B		A
TEMPUS AI, INC.	10.16B	-	A	-		-
PROMETHEUS BIOSCIENCES, INC.	9.56B	-	-	-	-	-	-	-
Average	19.39B		AA
Weighted average by Cap.			AA